Cabergoline is a medication primarily used to treat conditions associated with high levels of prolactin, such as prolactinomas and other disorders of the pituitary gland. It belongs to a class of drugs known as dopamine agonists, which work by stimulating dopamine receptors in the brain, thereby inhibiting prolactin secretion.
Dosage Guidelines for Cabergoline Tablets
The dosage of Cabergoline can vary based on the specific condition being treated, the patient’s response to therapy, and the prescribing physician’s recommendations. Below are general dosage guidelines:
- Initial Dosage: The typical starting dose for adults is 0.5 mg, taken twice a week.
- Adjustment of Dosage: Based on individual response, the dosage may be gradually increased in increments of 0.5 mg. It is advisable to not exceed a total weekly dose of 2 mg.
- Maximum Dosage: For most conditions, the maximum dosage is 1 mg, taken twice weekly.
- Monitoring: Regular monitoring by a healthcare provider is recommended to assess effectiveness and tolerability, making adjustments as necessary.
Administration and Precautions
Cabergoline tablets should be taken with food to minimize gastrointestinal side effects. Patients should be cautious when standing up quickly, as cabergoline may cause dizziness or fainting due to lowered blood pressure.
Always consult with a healthcare professional before starting or adjusting the dosage of Cabergoline, as individual health factors can significantly influence treatment outcomes.